Shariant platform: Enabling evidence sharing across Australian clinical genetic-testing laboratories to support variant interpretationEmma Tudini, Michael C. Quinn, Naomi L. Baker et al.|The American Journal of Human Genetics|2022Cited by 34
Next generation clonal neoantigen targeting T cells, generated using the PELEUS (TM) bioinformatics platform and the VELOS (TM) manufacturing method show superior reactivity and phenotypic characteristics than classical TIL productsEleni Kotsiou, Katy Newton, Tz Hou et al.|UCL Discovery (University College London)|2020Cited by 0